The Federal Trade Commission will hold a public workshop June 18 in Washington, D.C., to assess the impact of certificates of public advantage on health care prices, quality, access and innovation. “States have enacted COPAs with the assumption that regulatory oversight can mitigate the effects of lost competition and may allow hospitals to achieve certain efficiencies,” FTC said. “The Commission is interested in empirical research on the actual benefits and harms associated with COPAs, and on qualitative analyses of stakeholders’ experience with COPAs. Such studies and analyses, as well as the information presented at this workshop, may help advance the agency’s policy and enforcement strategies.” The workshop is part of FTC’s COPA Assessment Project.

Headline
The AHA Aug. 17 provided comments to the Centers for Medicare & Medicaid Services on its proposed rule to codify in regulation the Medicare Drug Price…
Headline
The AHA’s Community Health Improvement network will host a webinar Aug. 26 at noon ET that will feature discussion from leaders at CredibleMind on what a…
Headline
In this conversation, Baligh Yehia, M.D., president of Jefferson Health, shares how the organization is rethinking healthcare access through same-day cancer…
Headline
In this conversation, Michele Frankel, deputy market president for Northwell Health’s Eastern Market, and Susan Kwiatek, DNP, vice president of aging and…
Headline
The AHA July 31 provided comments to the Centers for Medicare & Medicaid Services on its interim final rule on Medicaid community engagement requirements.…
Headline
Current or prospective essential community providers, which are facilities serving predominantly low-income and medically underserved individuals, must update…